Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 12 | 2025 | 108 | 4.320 |
Why?
|
| Tonsillectomy | 8 | 2024 | 97 | 4.300 |
Why?
|
| Deglutition Disorders | 6 | 2023 | 132 | 3.750 |
Why?
|
| Middle Ear Ventilation | 9 | 2023 | 29 | 3.210 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2024 | 208 | 2.090 |
Why?
|
| Adenoidectomy | 6 | 2024 | 74 | 2.010 |
Why?
|
| Vocal Cord Paralysis | 4 | 2021 | 68 | 1.940 |
Why?
|
| Otitis Media | 7 | 2022 | 84 | 1.860 |
Why?
|
| Heart Defects, Congenital | 4 | 2023 | 1816 | 1.250 |
Why?
|
| Larynx | 2 | 2023 | 70 | 1.240 |
Why?
|
| Laryngoplasty | 2 | 2021 | 25 | 1.190 |
Why?
|
| Vocal Cords | 5 | 2023 | 65 | 1.180 |
Why?
|
| Evidence-Based Medicine | 6 | 2025 | 633 | 1.040 |
Why?
|
| Postoperative Complications | 6 | 2023 | 3068 | 1.020 |
Why?
|
| Preoperative Care | 2 | 2017 | 351 | 0.920 |
Why?
|
| Qualitative Research | 2 | 2025 | 548 | 0.920 |
Why?
|
| Otitis Media with Effusion | 3 | 2023 | 18 | 0.900 |
Why?
|
| Laryngeal Neoplasms | 2 | 2017 | 80 | 0.890 |
Why?
|
| Child | 34 | 2024 | 24463 | 0.840 |
Why?
|
| Mediastinal Emphysema | 1 | 2023 | 12 | 0.840 |
Why?
|
| Nose Deformities, Acquired | 2 | 2013 | 12 | 0.830 |
Why?
|
| Nasal Septum | 2 | 2013 | 17 | 0.820 |
Why?
|
| Nasal Mucosa | 2 | 2013 | 65 | 0.800 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2023 | 51 | 0.800 |
Why?
|
| Rhinoplasty | 2 | 2013 | 44 | 0.780 |
Why?
|
| Pneumothorax | 1 | 2023 | 79 | 0.780 |
Why?
|
| Laryngomalacia | 1 | 2021 | 11 | 0.740 |
Why?
|
| Glottis | 1 | 2021 | 31 | 0.740 |
Why?
|
| Surgical Flaps | 2 | 2013 | 204 | 0.710 |
Why?
|
| Private Sector | 1 | 2020 | 24 | 0.700 |
Why?
|
| Insurance, Health | 2 | 2020 | 138 | 0.680 |
Why?
|
| Caregivers | 2 | 2023 | 578 | 0.670 |
Why?
|
| Tonsillitis | 1 | 2019 | 13 | 0.650 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 188 | 0.610 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 18 | 0.610 |
Why?
|
| Humans | 54 | 2025 | 124822 | 0.600 |
Why?
|
| Medicaid | 1 | 2020 | 242 | 0.580 |
Why?
|
| Laryngectomy | 1 | 2017 | 25 | 0.570 |
Why?
|
| Audiometry | 1 | 2016 | 21 | 0.530 |
Why?
|
| Fellowships and Scholarships | 3 | 2016 | 277 | 0.520 |
Why?
|
| Career Choice | 3 | 2016 | 143 | 0.520 |
Why?
|
| Salvage Therapy | 1 | 2017 | 194 | 0.500 |
Why?
|
| Counseling | 1 | 2017 | 217 | 0.500 |
Why?
|
| Retrospective Studies | 17 | 2023 | 16296 | 0.500 |
Why?
|
| Music | 1 | 2015 | 17 | 0.500 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2015 | 18 | 0.500 |
Why?
|
| Hospital Charges | 1 | 2015 | 61 | 0.490 |
Why?
|
| Tracheal Stenosis | 1 | 2015 | 31 | 0.470 |
Why?
|
| Child, Preschool | 17 | 2023 | 14054 | 0.470 |
Why?
|
| Vocal Cord Dysfunction | 1 | 2014 | 8 | 0.460 |
Why?
|
| Laryngostenosis | 1 | 2015 | 37 | 0.460 |
Why?
|
| Hospital Costs | 1 | 2015 | 179 | 0.460 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 218 | 0.440 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2021 | 141 | 0.440 |
Why?
|
| Endoscopy | 1 | 2015 | 281 | 0.430 |
Why?
|
| Dyspnea | 1 | 2014 | 151 | 0.420 |
Why?
|
| Trachea | 1 | 2015 | 201 | 0.420 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 3729 | 0.400 |
Why?
|
| Tracheostomy | 1 | 2015 | 193 | 0.400 |
Why?
|
| Infant | 16 | 2023 | 12488 | 0.390 |
Why?
|
| Inpatients | 1 | 2015 | 499 | 0.380 |
Why?
|
| Quality of Life | 3 | 2022 | 1949 | 0.370 |
Why?
|
| Propranolol | 1 | 2011 | 128 | 0.360 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 515 | 0.360 |
Why?
|
| Otolaryngologists | 2 | 2023 | 9 | 0.350 |
Why?
|
| Electronic Health Records | 1 | 2017 | 725 | 0.350 |
Why?
|
| Hemangioma | 1 | 2011 | 94 | 0.350 |
Why?
|
| Male | 22 | 2024 | 61314 | 0.340 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 2902 | 0.340 |
Why?
|
| United States | 10 | 2024 | 10876 | 0.340 |
Why?
|
| Research Design | 2 | 2025 | 690 | 0.340 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 205 | 0.340 |
Why?
|
| Recurrence | 3 | 2019 | 1427 | 0.330 |
Why?
|
| Female | 20 | 2024 | 66580 | 0.310 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 3447 | 0.300 |
Why?
|
| Exercise | 1 | 2014 | 820 | 0.300 |
Why?
|
| Hearing Loss, Unilateral | 2 | 2018 | 7 | 0.300 |
Why?
|
| Hearing Aids | 2 | 2018 | 17 | 0.300 |
Why?
|
| Adolescent | 12 | 2024 | 19333 | 0.300 |
Why?
|
| Patient Selection | 4 | 2022 | 692 | 0.290 |
Why?
|
| Length of Stay | 3 | 2018 | 1311 | 0.260 |
Why?
|
| Infant, Newborn | 6 | 2022 | 8189 | 0.250 |
Why?
|
| Telemedicine | 2 | 2022 | 439 | 0.240 |
Why?
|
| Neck | 2 | 2023 | 137 | 0.240 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2024 | 27 | 0.230 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 607 | 0.230 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2883 | 0.220 |
Why?
|
| Audiology | 1 | 2023 | 5 | 0.220 |
Why?
|
| Acute Disease | 2 | 2017 | 1108 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 1267 | 0.210 |
Why?
|
| Prospective Studies | 4 | 2022 | 6139 | 0.210 |
Why?
|
| Healthcare Disparities | 3 | 2022 | 431 | 0.210 |
Why?
|
| Lymphangioma, Cystic | 1 | 2022 | 16 | 0.210 |
Why?
|
| Treatment Outcome | 7 | 2022 | 12342 | 0.210 |
Why?
|
| Cellulitis | 1 | 2023 | 64 | 0.200 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 316 | 0.200 |
Why?
|
| Perioperative Care | 1 | 2024 | 196 | 0.200 |
Why?
|
| Lymphatic Abnormalities | 1 | 2022 | 35 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 410 | 0.200 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 120 | 0.190 |
Why?
|
| Hearing Loss, Central | 1 | 2021 | 3 | 0.190 |
Why?
|
| Enteral Nutrition | 1 | 2023 | 256 | 0.190 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2022 | 71 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3589 | 0.180 |
Why?
|
| Hearing Loss | 2 | 2020 | 132 | 0.180 |
Why?
|
| Hearing | 2 | 2018 | 52 | 0.180 |
Why?
|
| Emotions | 1 | 2023 | 364 | 0.180 |
Why?
|
| Health Equity | 1 | 2022 | 57 | 0.180 |
Why?
|
| Body Weight | 1 | 2024 | 1005 | 0.170 |
Why?
|
| Adenoids | 1 | 2019 | 12 | 0.160 |
Why?
|
| Down Syndrome | 1 | 2022 | 198 | 0.160 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 36 | 0.160 |
Why?
|
| Pediatrics | 2 | 2020 | 1155 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 159 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 120 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 172 | 0.160 |
Why?
|
| Speech Therapy | 1 | 2018 | 10 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 307 | 0.150 |
Why?
|
| Oropharynx | 1 | 2018 | 34 | 0.150 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 319 | 0.150 |
Why?
|
| Social Class | 1 | 2018 | 193 | 0.140 |
Why?
|
| Insurance Claim Review | 1 | 2017 | 27 | 0.140 |
Why?
|
| Incidence | 2 | 2022 | 3144 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2024 | 1192 | 0.140 |
Why?
|
| Anxiety | 1 | 2023 | 966 | 0.140 |
Why?
|
| Speech Perception | 1 | 2017 | 49 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2019 | 444 | 0.140 |
Why?
|
| Military Medicine | 1 | 2017 | 49 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5156 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 233 | 0.130 |
Why?
|
| Prevalence | 1 | 2023 | 2450 | 0.130 |
Why?
|
| Echocardiography | 1 | 2021 | 1052 | 0.120 |
Why?
|
| Hypoglossal Nerve | 1 | 2015 | 12 | 0.120 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2015 | 16 | 0.120 |
Why?
|
| Physicians | 1 | 2022 | 582 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 1 | 2018 | 294 | 0.120 |
Why?
|
| Salivary Glands, Minor | 1 | 2015 | 10 | 0.120 |
Why?
|
| Health Care Costs | 1 | 2018 | 371 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1248 | 0.120 |
Why?
|
| Voice Training | 1 | 2014 | 5 | 0.120 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 55 | 0.120 |
Why?
|
| Disease Management | 1 | 2018 | 521 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2022 | 4786 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2018 | 547 | 0.110 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 267 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2092 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 1328 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2015 | 258 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2022 | 724 | 0.110 |
Why?
|
| Logistic Models | 1 | 2018 | 1811 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 567 | 0.100 |
Why?
|
| Head | 2 | 2023 | 103 | 0.100 |
Why?
|
| Leadership | 1 | 2014 | 228 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 3010 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2011 | 683 | 0.080 |
Why?
|
| Prognosis | 1 | 2018 | 4615 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 998 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2024 | 286 | 0.080 |
Why?
|
| Adult | 5 | 2024 | 29484 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 998 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 6312 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2014 | 1178 | 0.070 |
Why?
|
| Tympanoplasty | 1 | 2023 | 9 | 0.050 |
Why?
|
| Laryngoscopy | 2 | 2015 | 151 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2023 | 182 | 0.050 |
Why?
|
| Sclerotherapy | 1 | 2022 | 40 | 0.050 |
Why?
|
| Bias | 1 | 2023 | 131 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 150 | 0.050 |
Why?
|
| Furosemide | 1 | 2021 | 38 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2023 | 174 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 102 | 0.050 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2021 | 15 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2022 | 94 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 134 | 0.050 |
Why?
|
| Sirolimus | 1 | 2022 | 223 | 0.050 |
Why?
|
| Georgia | 1 | 2020 | 30 | 0.040 |
Why?
|
| Health Services Research | 1 | 2022 | 188 | 0.040 |
Why?
|
| Middle Aged | 2 | 2017 | 26730 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 19697 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 257 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 555 | 0.040 |
Why?
|
| Language Development | 1 | 2018 | 33 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2022 | 481 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 478 | 0.040 |
Why?
|
| Hearing Tests | 1 | 2017 | 13 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2427 | 0.030 |
Why?
|
| Age Factors | 2 | 2014 | 2820 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2018 | 175 | 0.030 |
Why?
|
| Decision Making | 1 | 2022 | 654 | 0.030 |
Why?
|
| Ethmoid Bone | 1 | 2015 | 8 | 0.030 |
Why?
|
| Maxilla | 1 | 2015 | 36 | 0.030 |
Why?
|
| Electromyography | 1 | 2015 | 165 | 0.030 |
Why?
|
| Voice | 1 | 2014 | 14 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 143 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 783 | 0.030 |
Why?
|
| Dogs | 1 | 2015 | 770 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 356 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2014 | 83 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 435 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 612 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1106 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 277 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 762 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 217 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 600 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1402 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1285 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1135 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10275 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4356 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3436 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 8993 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 34195 | 0.010 |
Why?
|